Deborah Ann Smith

机构：University of Alabama in Huntsville · ORCID：0000-0003-1118-2041

发表论文 192 篇 · 总被引 7223 次 · h-index 42

代表论文

• A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors (2017 · Clinical Cancer Research · 被引 149)
• First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies (2015 · Clinical Cancer Research · 被引 115)
• Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors (2019 · Journal of Nuclear Medicine · 被引 80)
• PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours (2018 · Clinical and Translational Radiation Oncology · 被引 77)
• DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM) (2020 · Blood · 被引 49)
• Blocking two-component signalling enhances Candida albicans virulence and reveals adaptive mechanisms that counteract sustained SAPK activation (2017 · PLoS Pathogens · 被引 42)